Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic
  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Global Lung Marker Research Report 2024-2032: Rising Incidences of Respiratory Disorders Such as of Pleural Effusion, Pleural Mesothelioma, Pleural Plaque Driving Demand - ResearchAndMarkets.com

The "Global Lung Marker Market Report by Cancer Type, Marker Type, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.

The global lung marker market size reached US$ 438.2 Million in 2023. Looking forward, the market is projected to reach US$ 1.06 billion by 2032, exhibiting a growth rate (CAGR) of 10.36% during 2023-2032.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders.

Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers.

In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Questions Answered in This Report

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry?

Key Attributes:

Report Attribute Details
No. of Pages 137
Forecast Period 2023 - 2032
Estimated Market Value (USD) in 2023 $438.2 Million
Forecasted Market Value (USD) by 2032 $1060 Million
Compound Annual Growth Rate 10.3%
Regions Covered Global

Competitive Landscape

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Beckman Coulter Inc.
  • Fujirebio Europe N.V.
  • Hologic Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers
  • BioSpace Inc.

Key Market Segmentation

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others

Breakup by End User:

  • Hospitals
  • Diagnostic Labs
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Others
  • Middle East and Africa
  • Turkey
  • Iran
  • Others

For more information about this report visit https://www.researchandmarkets.com/r/595ee8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.